Delivery Order SPE2DB25D3306-SPE2DB25FUBZM
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,803.07 on September 15, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count). This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania, and an ultimate completion date of September 16, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,058.52 for Mesalamine DR 1.2 GM tablets (120 count) on July 10, 2025, with an ultimate completion date of July 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $3,334.85 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $15,421.08 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This firm fixed-price delivery order, with an ultimate completion date of October 30, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $3,539.98 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,704.12 to AmerisourceBergen Drug Corp for the supply of Mesalamine 800 mg delayed-release tablets (180 count) with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $5,366.85 delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 1.2 GM tablets (120-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a ceiling value of $1,512.73. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,923.46 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count) with a completion date of October 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order transaction under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,615.86 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This firm fixed-price delivery order, issued on May 15, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by May 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUBZMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,170.31 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) on June 18, 2025, with completion scheduled for June 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its substantial Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order supports the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceuticals and medical supplies for military and veteran healthcare systems. Mesalamine is a gastrointestinal anti-inflammatory medication commonly used in military medical supply chains. This award reflects AmerisourceBergen Drug Corp's ongoing role as a primary pharmaceutical vendor for the Department of Defense, demonstrating the company's capability to fulfill competitive federal procurement requirements across a diverse portfolio of medical products and therapeutic domains. The parent IDC enables efficient delivery of pharmaceutical commodities to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 6/18/25 |